Abdul Mannan: The Dual Biology of the Sickle Cell Mutation
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn about an article by Gavin Band et al. published in Nature, adding:
“The sickle mutation is not simply ‘protective’.
It depends on whether you inherit one copy or two.
That is the whole paradox.
Here’s the simple version:
- HbAS protects because the parasite creates local hypoxia inside the red cell
- That triggers limited HbS polymerisation
- The infected red cell sickles
- A working spleen clears it, parasite included
- Less PfEMP1 reaches the cell surface, so there is less adhesion and rosetting
But HbSS is different:
- The spleen is often lost early through repeated infarction
- Red cells are already under sickling stress
- There is no HbA buffer
- Baseline anaemia leaves little reserve
- Malaria then adds haemolysis on top of haemolysis
So the same mutation can act like a trap in HbAS, but becomes a liability in HbSS.
A 2022 Nature paper by Band et al. added another layer: HbS protection also depends on parasite genotype, with Pfsa1, Pfsa2 and Pfsa3 loci linked to parasites that can cause severe malaria despite HbS.
For trainees, this is a beautiful teaching point:
Genetics is never isolated from environment.
And malaria wrote part of the sickle cell story.
What is your favourite example of evolution shaping haematology?”
Title: Malaria protection due to sickle haemoglobin depends on parasite genotype
Authors: Gavin Band, Ellen M. Leffler, Muminatou Jallow, Fatoumatta Sisay-Joof, Carolyne M. Ndila, Alexander W. Macharia, Christina Hubbart, Anna E. Jeffreys, Kate Rowlands, Thuy Nguyen, Sónia Gonçalves, Cristina V. Ariani, Jim Stalker, Richard D. Pearson, Roberto Amato, Eleanor Drury, Giorgio Sirugo, Umberto d’Alessandro, Kalifa A. Bojang, Kevin Marsh, Norbert Peshu, Joseph W. Saelens, Mahamadou Diakité, Steve M. Taylor, David J. Conway, Thomas N. Williams, Kirk A. Rockett, Dominic P. Kwiatkowski

Other posts featuring Abdul Mannan on Hemostasis Today.
-
Nov 12, 2026, 16:35Mohamed Hesham Gamal: Intravenous Thrombolysis Shows Strong Safety Profile in Stroke Mimics
-
Nov 12, 2026, 14:35Mokhtar Tazik: Connecting Clinical Demand with Plasma Collection and Fractionation Capacity
-
Nov 12, 2026, 14:25Kim Phelan: Celebrating Dr. Marilyn Manco-Johnson as a Recipient of the 2026 Eternal Spirit Award
-
Nov 12, 2026, 14:20Shailesh Kucha: Ensuring Transfusion Safety Through Biochemical Assessment of Stored Red Cells
-
Nov 12, 2026, 14:20Akshat Jain: Wonderful Time Presenting at the ATHN 2026
-
Nov 12, 2026, 14:08Elisa Gabinaud: The Evolving Science of Megakaryocyte Development
-
Nov 12, 2026, 13:57Seyed Mohammad Sadegh Pezeshki: When Microcytosis Reveals a Complex Hemoglobinopathy
-
Nov 12, 2026, 13:45Danny Hsu: THANZ Highlights Antiphospholipid Syndrome in Upcoming Educational Webinar
-
Nov 12, 2026, 13:04Wuhan Thrombosis Congress 2026 – Bringing Global Experts Together – ISTH